This study aims to investigate the biochemical alterations in blood and body fluids of patients diagnosed with tuberculosis (TB), focusing on identifying potential biomarkers that reflect the disease's severity and progression. A total of [insert number] participants were recruited, comprising [insert number] confirmed TB patients and [insert number] healthy controls. Blood and body fluid samples, including pleural fluid and cerebrospinal fluid (CSF), were collected for analysis. Key biochemical parameters, such as serum electrolytes, liver and kidney function markers, inflammatory cytokines, and metabolic indicators, were measured using standardized laboratory techniques.

The results demonstrated significant deviations in the biochemical profiles of TB patients compared to healthy controls. Notably, elevated levels of inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6), were observed, correlating with disease severity and extent of lung involvement. Liver function tests revealed increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating hepatic stress in TB patients. Moreover, analysis of body fluids showed distinct biochemical signatures, with pleural fluid exhibiting higher concentrations of proteins and specific cytokines compared to serum, suggesting localized inflammatory responses.

These findings highlight the importance of biochemical profiling in understanding the pathophysiological changes associated with tuberculosis. The identified biomarkers could serve as valuable tools for early diagnosis, monitoring treatment response, and assessing disease prognosis. Ultimately, this study contributes to the growing body of evidence supporting the role of biochemical alterations in the management and understanding of tuberculosis, paving the way for future research into targeted therapeutic strategies.

Biochemical profiling, tuberculosis, blood analysis

Agarwal MK, Nath J, Mukerji PK, Srivastava VML. A study of serum Adenosine deaminase activity in sputum negative patients of pulmonary tuberculosis. Ind J Tub 1991; 38:139-141.

Maher D, Chaulet P, Spinaci S, Harries A (1997). Treatment of tuberculosis: Guidelines for National Programmes, 2nd Ed. Geneva: World Health Organization.

Centres for Disease Control and Prevention (CDC). "Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004" MMWR Morb Mortal Wkly Rep2006;55(1 1):301-5.

Dimakou K, Hillas G, Bakakos P Adenosinedeaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis. Int J Tuberc Lung Dis2009;13(6):744-748.

Shah N, Asian N (1992). Adenosine deaminase activity levels and its diagnostic value. Pak Med J1992;251 :217-221.

FerraraG, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D'Amico R, Marchegiano P, Rumpianesi F. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Grit Care Med2005; 172:631-635.

Tillet W, Francis TW. Origin of CRP and its uses. Chest 1930; 30:151-96.

Harada N (2006). Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay. Kekkaku 2006;81(11):681-6.

Dacie JV, Lewis SM. Haematological tests. Practical haematology; Edinburgh: Churchill Living stone; 20061:54-78

Giusti G, Galanti B. Adenosine deaminase. In: Hergmyer HU (RD). Method of enzymatic analysis. New York: Verlag Chemic Weinhein and Academic Press1974:1092-1099.

Kidmark CO. C-reactive protein. Scand J Clin Lab Invest, 1972;29:407.

Mori T, Yamagishi F. Specific detection of tuberculosis infection: an interferon-g--based assay using new antigens. Chest, 2005;64:563-972.

Atalay F, Ernam D, Hasanoglu HC, Karalezli A, Kaplan O. Pleural adenosine deaminase in the separation of transudative and exudative pleural effusions. Clin Biochem2005;38(12): 1066-1 070.

Jadhav, Bardapurkar J. Diagnostic value of adenosine deaminase to differentiate exudates and transudates. Indian J Physiol Pharmaco/2007:51(2):170-174.

Prakash, Reiman: Pleural effusion: normal pleural biopsy or fluid cytology did not rule out malignancy. Mayo Clinical Protocols1985; 60:158-164